Furthermore, drugs that can act as insulin sensitizers and/or bypass insulin resistance in the brain offer a unique opportunity to address cognitive deficits and improve lives of the patients with schizophrenia(Agarwal et al., 2019). This evidence concerns the gene INS and Insulin resistance.